Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ)
CNY 13.63
(0.15%)
CNY 13.63
(0.15%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 518.26 Million CNY | 15.63% |
| 2022 | 446.78 Million CNY | 4.14% |
| 2021 | 429.03 Million CNY | 20.94% |
| 2020 | 354.73 Million CNY | -24.43% |
| 2019 | 469.41 Million CNY | -5.79% |
| 2018 | 498.25 Million CNY | -11.76% |
| 2017 | 564.66 Million CNY | 20.82% |
| 2016 | 467.34 Million CNY | 10.48% |
| 2015 | 423 Million CNY | -19.19% |
| 2014 | 523.43 Million CNY | 8.01% |
| 2013 | 484.62 Million CNY | 21.59% |
| 2012 | 398.57 Million CNY | 9.89% |
| 2011 | 362.7 Million CNY | 15.94% |
| 2010 | 312.84 Million CNY | -15.44% |
| 2009 | 369.95 Million CNY | 13.23% |
| 2008 | 326.72 Million CNY | 12.98% |
| 2007 | 289.17 Million CNY | 25.47% |
| 2006 | 230.47 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 228.02 Million CNY | 79.22% |
| 2024 Q3 | 109.73 Million CNY | -51.88% |
| 2024 Q1 | 127.22 Million CNY | 228.88% |
| 2023 FY | 516.6 Million CNY | 15.63% |
| 2023 Q4 | 38.68 Million CNY | -12.2% |
| 2023 Q1 | 214.66 Million CNY | 350.59% |
| 2023 Q2 | 219.19 Million CNY | 2.11% |
| 2023 Q3 | 44.06 Million CNY | -79.9% |
| 2022 Q4 | 47.63 Million CNY | 17.7% |
| 2022 Q3 | 40.47 Million CNY | -80.31% |
| 2022 Q2 | 205.55 Million CNY | 34.25% |
| 2022 Q1 | 153.11 Million CNY | 125.84% |
| 2022 FY | 446.78 Million CNY | 4.14% |
| 2021 Q3 | 67.89 Million CNY | -60.8% |
| 2021 Q1 | 120.14 Million CNY | 1164.58% |
| 2021 Q2 | 173.19 Million CNY | 44.15% |
| 2021 FY | 429.03 Million CNY | 20.94% |
| 2021 Q4 | 67.79 Million CNY | -0.15% |
| 2020 Q3 | 82.67 Million CNY | -56.18% |
| 2020 Q1 | 94.67 Million CNY | 25.2% |
| 2020 FY | 354.73 Million CNY | -24.43% |
| 2020 Q4 | -11.28 Million CNY | -113.65% |
| 2020 Q2 | 188.67 Million CNY | 99.29% |
| 2019 Q1 | 108.12 Million CNY | 64.96% |
| 2019 FY | 469.41 Million CNY | -5.79% |
| 2019 Q4 | 75.62 Million CNY | 6.25% |
| 2019 Q3 | 71.17 Million CNY | -66.82% |
| 2019 Q2 | 214.49 Million CNY | 98.38% |
| 2018 FY | 498.25 Million CNY | -11.76% |
| 2018 Q4 | 65.54 Million CNY | -43.1% |
| 2018 Q3 | 115.19 Million CNY | -46.31% |
| 2018 Q2 | 214.54 Million CNY | 108.35% |
| 2018 Q1 | 102.97 Million CNY | -36.88% |
| 2017 Q3 | 112.43 Million CNY | -43.1% |
| 2017 Q1 | 91.49 Million CNY | -11.6% |
| 2017 FY | 564.66 Million CNY | 20.82% |
| 2017 Q4 | 163.13 Million CNY | 45.09% |
| 2017 Q2 | 197.59 Million CNY | 115.97% |
| 2016 Q3 | 102.92 Million CNY | -41.21% |
| 2016 FY | 467.34 Million CNY | 10.48% |
| 2016 Q4 | 103.49 Million CNY | 0.56% |
| 2016 Q1 | 85.14 Million CNY | -7.01% |
| 2016 Q2 | 175.08 Million CNY | 105.62% |
| 2015 Q2 | 194.53 Million CNY | 223.76% |
| 2015 Q4 | 91.56 Million CNY | 19.2% |
| 2015 FY | 423 Million CNY | -19.19% |
| 2015 Q1 | 60.08 Million CNY | -57.98% |
| 2015 Q3 | 76.81 Million CNY | -60.51% |
| 2014 Q2 | 192.85 Million CNY | 127.33% |
| 2014 FY | 523.43 Million CNY | 8.01% |
| 2014 Q4 | 142.98 Million CNY | 39.13% |
| 2014 Q3 | 102.76 Million CNY | -46.71% |
| 2014 Q1 | 84.83 Million CNY | -25.96% |
| 2013 Q4 | 114.57 Million CNY | 5.72% |
| 2013 FY | 484.62 Million CNY | 21.59% |
| 2013 Q1 | 86.85 Million CNY | 7.87% |
| 2013 Q2 | 172.43 Million CNY | 98.52% |
| 2013 Q3 | 108.37 Million CNY | -37.15% |
| 2012 Q2 | 152.05 Million CNY | 101.71% |
| 2012 FY | 398.57 Million CNY | 9.89% |
| 2012 Q4 | 80.51 Million CNY | -11.14% |
| 2012 Q1 | 75.38 Million CNY | -1.43% |
| 2012 Q3 | 90.61 Million CNY | -40.41% |
| 2011 Q3 | 88.37 Million CNY | -35.77% |
| 2011 Q1 | 60.25 Million CNY | 8.56% |
| 2011 Q2 | 137.59 Million CNY | 128.35% |
| 2011 FY | 362.7 Million CNY | 15.94% |
| 2011 Q4 | 76.48 Million CNY | -13.46% |
| 2010 Q4 | 55.5 Million CNY | -27.87% |
| 2010 Q3 | 76.94 Million CNY | -37.45% |
| 2010 FY | 312.84 Million CNY | -15.44% |
| 2010 Q1 | 57.37 Million CNY | -37.5% |
| 2010 Q2 | 123.02 Million CNY | 114.43% |
| 2009 Q4 | 91.79 Million CNY | 4.45% |
| 2009 Q3 | 87.88 Million CNY | -41.82% |
| 2009 Q2 | 151.06 Million CNY | 285.25% |
| 2009 FY | 369.95 Million CNY | 13.23% |
| 2009 Q1 | 39.21 Million CNY | -59.44% |
| 2008 Q3 | 61.62 Million CNY | 0.0% |
| 2008 Q4 | 96.67 Million CNY | 56.88% |
| 2008 FY | 326.72 Million CNY | 12.98% |
| 2007 FY | 289.17 Million CNY | 25.47% |
| 2006 FY | 230.47 Million CNY | 0.0% |